FI6v3

N/A

Report date: 2025/04/14 16:57:33

Base Information

Drug NameFI6v3
Drug Alias NameFI-6-v-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Influenza virus hemagglutinin glycoproteins
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHumabs Biomed SaVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesHumabs Biomed Sa
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A